Address: 107031, Москва, Трубная площадь, дом 2, Бизнес-центр ‘Неглинная Плаза’,Russia
Tel: +7 (495) 229-29-99
Web: http://www.roche.ru/portal/roche.ru
Roche’ subsidiary in Russia was opened in 1991 and since then the company’s biotechnological medicines for the treatment of cancer, severe virus infections, autoimmune inflammatory diseases and metabolic disorders are widely marketed in Russia. The headquarters are located in Moscow, with subsidiaries in Saint-Petersburg and Novosibirsk. Roche’s development of novel and highly effective medicines is the result of numerous clinical trials conducted by the company according to GCP (Good Clinical Practice) worldwide, including Russia. Clinical trials in Russia are performed in the context of long-term cooperation with major Russian research centers. The leaders among them are Russian N.N. Blokhin Oncology Scientific Center in Moscow, Prof. N.N. Petrov Cancer Research Institute in Saint-Petersburg, Republican Oncology Center and AIDS Center in Kazan and many others. Roche closely monitors the quality of both local trials and parts of multinational clinical projects conducted in Russia.
A large number of Roche’s medicines are included into the Federal Reimbursement List due to the Federal program of reimbursement of certain categories of citizens. The company is a Good Corporate Citizen and takes an active part in social healthcare projects and initiatives. Roche supports the Equal Right to Life program initiated by oncologists. The goal of the program is to implement modern technologies of cancer diagnostics and treatment into regional healthcare institutions and to provide equal opportunities to proper treatment to all patients regardless of their social status or location.
Additional information on Roche in Russia can be found at www.roche.ru
The Roche company was founded in 1896 in Basel, Switzerland. At present Roche has subsidiaries in 150 countries worldwide and employs over 80,000 people. The investment in research and development in 2010 was over 9 billion Swiss francs , with Group sales of 47,5 billion Swiss francs. Roche wholly owns Genentech, USA and has a majority stake in Chugai Pharmaceutical, Japan.
Roche is one of the leading global pharmaceutical companies and the world’s leader in in vitro diagnostics and tissue-based cancer diagnostics. Personalised medicine strategy allows Roche to develop novel medicines and diagnostics tools that save and prolong patients’ lives significantly improving their quality of life.
Although Russian authorities received heavy criticism for approving the Sputnik V vaccine prior to the completion of Phase III clinical trials, the jab is increasingly being seen as a viable…
Russia has announced that a domestically developed COVID-19 vaccine has been approved by its health authorities, the first such approval globally. However, with large-scale Phase III trials having not yet…
Below is a selection of top stories in Russian pharma from recent months, ranging from proposed changes in legislation, labelling system updates, priorities set forth by the country’s manufacturing association…
Russia is facing a drug shortage crisis which is having a particular impact on patients with life-threatening conditions. A combination of geopolitical and bureaucratic issues are restricting the flow of…
In the latest twist in the ongoing story of Russian interference in the US presidential elections of 2016, it has emerged that Russian internet trolls and automated bots spread misinformation…
In the United States, Johnson & Johnson has an image of being very close to people. Americans grow up with this company — from baby shampoo, to Tylenol when they…
You took over this organization just three months ago, having previously headed businesses in industries as diverse as retail, food, and automobiles. What drew you to Alliance Healthcare Russia? Do…
The ARPM was founded in 2002, and you were its director from 2002-2004, before leaving for a post at the Roszdravnadzor. You’ve since rejoined as director since 2007. The organization…
When Focus Reports prepared a report on the French pharmaceutical industry in 2009/10, we found that the head of the main multinational pharmaceutical association had taken a career path quite…
The U.S. and Russia have a long history of trade, and you have personally been with the American Chamber of Commerce in Russia since 2001. Can you give a brief…
The primary objectives of this association are to promote Russia as a clinical trial destination, optimize the regulatory and legislative environment, and promote the interests of ACTO members. Can you…
You have said that AstraZeneca intends to be “in Russia for Russia” and the company has recently announced a large-scale investment in this country, financing a $150Mn domestic facility in…
See our Cookie Privacy Policy Here
